Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting survival in heart failure.

Viorel G Florea1, Inder S Anand

  • 1Heart Failure Program, VA Medical Center, One Veterans Drive, 111-C, Minneapolis, MN 55417, USA.

Current Cardiology Reports
|May 2, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of the HFpEF-ABA, H<sub>2</sub>FPEF, and HFA-PEFF Algorithms in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Clinical Trials.

Journal of cardiac failure·2026
Same author

Heart rate and atrial fibrillation/flutter in HFmrEF/HFpEF: a participant-level analysis across five randomized clinical trials.

European journal of heart failure·2026
Same author

Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.

Journal of the American College of Cardiology·2025
Same author

Adiposity-Related Anthropometrics and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Clinical Trials.

Journal of the American College of Cardiology·2025
Same author

Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF.

European heart journal. Cardiovascular pharmacotherapy·2025
Same author

Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials.

JACC. Heart failure·2025

Heart failure survival prediction is complex, with many factors like etiology, clinical signs, and biomarkers influencing outcomes. This review examines established markers to assess the accuracy of predicting patient survival in heart failure.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Heart failure (HF) presents a significant therapeutic challenge despite advancements in cardiovascular disorder treatments.
  • Prognosis for patients with heart failure remains poor, necessitating improved understanding of survival predictors.
  • Numerous factors, including etiology, clinical presentation, and ventricular performance, are linked to HF patient survival.

Purpose of the Study:

  • To review established prognostic markers for patients diagnosed with heart failure.
  • To evaluate the current accuracy and limitations in predicting survival for individuals with heart failure.

Main Methods:

  • Literature review of established predictive markers for heart failure survival.
  • Discussion of the role of clinical, functional, neurohormonal, inflammatory, and necrosis markers.

Related Experiment Videos

  • Analysis of the predictive power of these markers in the context of heart failure management.

    • Main Results:

    • Established markers for heart failure survival include etiology, clinical presentation, exercise capacity, and neurohormones.
    • Emerging markers such as inflammatory and necrosis markers are also associated with heart failure prognosis.
    • The collective predictive accuracy of current markers for heart failure survival requires further investigation.

    Conclusions:

    • While numerous factors influence heart failure prognosis, accurately predicting survival remains a complex clinical challenge.
    • Continued research into novel biomarkers and integrated predictive models is essential for improving heart failure patient outcomes.
    • Understanding established and emerging predictive markers is crucial for optimizing heart failure patient care and management strategies.